Cargando…
Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents
Arylimidamide (AIA) compounds containing two pyridylimidamide terminal groups (bis-AIAs) possess outstanding in vitro antileishmanial activity, and the frontrunner bis-AIA DB766 (2,5-bis[2-(2-isopropoxy)-4-(2-pyridylimino)aminophenyl]furan) is active in visceral leishmaniasis models when given orall...
Autores principales: | Zhu, Xiaohua, Farahat, Abdelbasset A., Mattamana, Meena, Joice, April, Pandharkar, Trupti, Holt, Elizabeth, Banerjee, Moloy, Gragg, Jamie L., Hu, Laixing, Kumar, Arvind, Yang, Sihyung, Wang, Michael Zhuo, Boykin, David W., Werbovetz, Karl A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841789/ https://www.ncbi.nlm.nih.gov/pubmed/27048943 http://dx.doi.org/10.1016/j.bmcl.2016.03.082 |
Ejemplares similares
-
Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection
por: da Silva, Cristiane França, et al.
Publicado: (2017) -
Antileishmanial Activity of a Series of N(2),N(4)-Disubstituted
Quinazoline-2,4-diamines
por: Van Horn, Kurt S., et al.
Publicado: (2014) -
In Vitro and In Vivo Investigation of the Efficacy of Arylimidamide DB1831 and Its Mesylated Salt Form - DB1965 - against Trypanosoma cruzi Infection
por: da Silva, Cristiane França, et al.
Publicado: (2012) -
Arylimidamides Have Potential for Chemoprophylaxis against Blood-Transmitted Chagas Disease
por: Timm, Bruno Lisboa, et al.
Publicado: (2023) -
Thermodynamic Factors That Drive Sequence-Specific DNA Binding of Designed, Synthetic Minor Groove Binding Agents
por: Paul, Ananya, et al.
Publicado: (2022)